Sustained diabetes risk reduction after real life and primary health care setting implementation of the diabetes in Europe prevention using lifestyle, physical activity and nutritional intervention (DE-PLAN) project by Gilis-Januszewska, Aleksandra et al.
Gilis-Januszewska et al. BMC Public Health  (2017) 17:198 
DOI 10.1186/s12889-017-4104-3RESEARCH ARTICLE Open AccessSustained diabetes risk reduction after real
life and primary health care setting
implementation of the diabetes in Europe
prevention using lifestyle, physical activity
and nutritional intervention (DE-PLAN)
project
Aleksandra Gilis-Januszewska1* , Jaana Lindström2, Jaakko Tuomilehto3,4,5,6,7, Beata Piwońska-Solska1,
Roman Topór-Mądry8, Zbigniew Szybiński1, Markku Peltonen2, Peter E. H. Schwarz9, Adam Windak10
and Alicja Hubalewska-Dydejczyk1Abstract
Background: Real life implementation studies performed in different settings and populations proved that lifestyle
interventions in prevention of type 2 diabetes can be effective. However, little is known about long term results of
these translational studies. Therefore, the purpose of this study was to examine the maintenance of diabetes type 2 risk
factor reduction achieved 1 year after intervention and during 3 year follow-up in primary health care setting in Poland.
Methods: Study participants (n = 262), middle aged, slightly obese, with increased type 2 diabetes risk
((age 55.5 (SD = 11.3), BMI 32 (SD = 4.8), Finnish Diabetes Risk Score FINDRISC 18.4 (SD = 2.9)) but no diabetes at baseline,
were invited for 1 individual and 10 group lifestyle counselling sessions as well as received 6 motivational phone calls and
2 letters followed by organized physical activity sessions combined with counselling to increase physical activity.
Measurements were performed at baseline and then repeated 1 and 3 years after the initiation of the intervention.
Results: One hundred five participants completed all 3 examinations (baseline age 56.6 (SD = 10.7)), BMI
31.1 (SD = 4.9)), FINDRISC 18.57 (SD = 3.09)). Males comprised 13% of the group, 10% of the patients presented
impaired fasting glucose (IFG) and 14% impaired glucose tolerance (IGT). Mean weight of participants decreased by
2.27 kg (SD = 5.25) after 1 year (p = <0.001). After 3 years a weight gain by 1.13 kg (SD = 4.6) (p = 0.04) was observed.
In comparison with baseline however, the mean total weight loss at the end of the study was maintained by 1.14 kg
(SD = 5.8) (ns). Diabetes risk (FINDRISC) declined after one year by 2.8 (SD = 3.6) (p = 0.001) and the decrease by
2.26 (SD = 4.27) was maintained after 3 years (p = 0.001). Body mass reduction by >5% was achieved after 1 and
3 years by 27 and 19% of the participants, respectively.
Repeated measures analysis revealed significant changes observed from baseline to year 1 and year 3 in: weight
(p = 0.048), BMI (p = 0.001), total cholesterol (p = 0.013), TG (p = 0.061), fasting glucose level (p = 0.037) and FINDRISC
(p = 0.001) parameters. The conversion rate to diabetes was 2% after 1 year and 7% after 3 years.
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Conclusions: Type 2 diabetes prevention in real life primary health care setting through lifestyle intervention delivered
by trained nurses leads to modest weight reduction, favorable cardiovascular risk factors changes and decrease of
diabetes risk. These beneficial outcomes can be maintained at a 3-year follow-up.
Trial registration: ISRCTN, ID ISRCTN96692060, registered 03.08.2016 retrospectively
Keywords: Diabetes type 2 prevention, Lifestyle intervention, Diet, Physical activity, Risk factors, Real life settingBackground
Randomized control trials (RCT) performed in different
populations have demonstrated up to 60% reduction in
type 2 diabetes incidence through lifestyle intervention
which leads to dietary and physical activity changes [1–4].
Furthermore, the effect of interventions in RCT setting
has been shown to continue up to 20 years with 34–43%
diabetes risk reduction [5–8]. Typically, the interventions
in these clinical efficacy trials have been intensive and
thus costly. Therefore, EU initiated and sponsored the
DE-PLAN project (Diabetes in Europe: Prevention Using
Lifestyle, Physical Activity and Nutritional Intervention)
as a real life implementation study in 17 countries in
Europe [9]. The aim of the project was to assess the reach
of the programs, adoption and implementation in diverse
real life settings, but also to create a network of trained
and experienced professionals to continue diabetes pre-
vention across Europe [9]. Indeed, real life implementation
studies conducted in different settings and populations
proved that less intensive, lower budget lifestyle interven-
tions can be effective [10–21]. However, little is known
about the long term results of these translational studies.
Therefore, the purpose of this study was to examine the
maintenance of risk factor reduction during 3 year follow-
up in real life, primary health care setting in Poland.
Methods
Design
The intervention conducted in the DE-PLAN project
was based on the principles of the Diabetes Prevention
Study [1, 9]. Given that the efficacy of lifestyle modifica-
tion treatments has been well established by earlier dia-
betes prevention trials, the need for an additional
randomized controlled trial study design in the current
program was regarded as unnecessary and unethical. A
detailed description of the program performed in
Poland, including the inclusion criteria, the characteris-
tic of participants, methods, the intervention and one-
year results has been published previously [10].
Participants
The study was performed in 9 independent primary
health care General Practitioners (GP) practices in
Krakow. The study group consisted of everyday patients,
city inhabitants, aged over 25. The inclusion criterionwas high diabetes risk assessed with the Finnish Diabetes
Risk Score (FINDRISC) > 14) (33% chance of developing
diabetes within 10 years) [22], the exclusion criteria was
either known diabetes or oral glucose tolerance test
(OGTT) screening diabetes as well as known chronic dis-
ease which could affect the results of the study. Advertise-
ments were placed alongside self-screening questionnaires
in the GPs’ waiting rooms. In addition, patients with
known risk factors were directly approached by nursing
and medical staff. Out of 800 leaflets with the FRS ques-
tionnaire distributed in co-operating practices, 566 were
completed. 368 respondents scored FRS >14; 275 agreed
to undergo OGTT examination and subsequently 262
(with all measurements done) were invited to participate
in the intervention. 175 participants completed the inter-
vention and the final examination after 1 year and 113
completed follow-up examination after 3 years. 9 people
(8 with complete measurements) who participated in the
3 year follow-up did not participate in 1 year examination.
105 patients took part in all 3 measurements (completers)
while 79 did not participate in the 1 year and 3 year
follow-up examinations (non-completers). The most com-
monly declared non-participation reason was shortage of
time and inability to continue “time-consuming program”.
Intervention
Lifestyle intervention implemented the principles of the
Diabetes Prevention Study [1] and was based on rein-
forced behavior modification focusing on five lifestyle
goals: loss of initial weight, reduced intake of total and
saturated fats, increased consumption of fruit, vegetables
and fiber and increased physical activity [1, 9, 10]. The
intervention curriculum was created on the basis of writ-
ten materials containing basic information about dia-
betes, diabetes prevention, diet, diet examples booklet
and information about physical activity.
Well-trained nurses (2 nurses per one center), certified
in diabetes prevention, delivered 10-month intervention.
The initial intensive phase of intervention (4 months)
consisted of 1 individual session followed by 10 group
sessions (10–14 people), focusing on diet and physical
activity changes. During each session printed educational
materials related to the topic of the session were distrib-
uted. Social support was emphasized by the group set-
ting and participants were also encouraged to invite
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spouse or other family member could also participate in
the sessions. After the initial 4 weeks of the intervention
patients could take part in physical activity sessions
twice a week (once a week – aqua aerobics; once a week
– gymnastics or football). The following maintenance
phase of the intervention (month: 4–10) following the
intensive phase consisted of six motivational telephone
sessions and two motivational letters received by the
participants [1, 9, 10]. There were no other post-
intervention contacts with the participants except mea-
surements in year 1 and 3.Table 1 Baseline characteristic of completers (n = 105) and
non-completers (n = 79) of 1 year and 3 year examination
Completers Non-completers P value
Mean/% SD Mean SD
Age 56,55 10,66 54,35 12,42 0,199
% men 13 32 0.004
Weight (kg) 82,85 15,20 89,70 15,73 0,003
BMI (kg/m2) 31,10 4,93 32,66 4,58 0,031
WC (cm) 96,67 11,41 101,23 9,41 0,004
SBP (mmHg) 130,72 14,09 134,80 13,77 0,051
DBP (mmHg) 80,80 8,97 83,47 10,08 0,060
Fasting glucose (mmol/l) 5,22 0,72 5,55 1,02 0,010
2-h OGTT glucose (mmol/l) 5,78 1,75 7,11 3,04 0,000
TCH (mmol/l) 5,55 0,94 5,81 1,30 0,127
HDL (mmol/l) 1,39 0,35 1,36 0,36 0,564
TG (mmol/l) 1,77 1,38 2,37 2,51 0,040Measurements
Patients were examined at baseline as well as after 12
and 36 months of the study. The examination procedure
included: questionnaires (FINDRISC, baseline, clinical
and lifestyle and quality of life) and biochemical tests
including: fasting and 120’OGTT glucose, serum tri-
glycerides, HDL and total cholesterol. Impaired Fasting
Glucose (IFG) was defined as fasting plasma glucose
concentration of 6.1 to 7.0 mmol/l. Impaired Glucose
Tolerance (IGT) was defined as glucose plasma concen-
tration of 7.80 to 11.0 mmol/l after oral administration
of 75 g of glucose (OGTT), diabetes mellitus (DM) was
defined as fasting glucose concentration of more than
7.0 mmol/l [23]. Body mass index (BMI) was calculated
as weight (in light indoor clothes, kg) divided by height
squared (m2), waist circumference was measured mid-
way between the lowest rib and iliac crest, diastolic and
systolic blood pressure were taken while sitting after 10
min rest.FINDRISC 18,57 3,09 18,82 2,95 0,584











Married/having a partner% 66 72 0.22Ethics
This study followed the Good Clinical Practice guidelines
and the guidelines of the Helsinki Declaration. The study
protocol was approved by the Jagiellonian University











Smoking currently 15 23 0.133
History of increased glucose
History of hypertension 71 76 0.256
History of hyperlipidaemia 46 51 0.304
History of depression
History of CVD
Family history of diabetes 62 67 0.285
Key: BMI body mass index, SBP systolic blood pressure, DBP diastolic blood
pressure, OGTT oral glucose tolerance test, TCH total cholesterol, HDL high
density lipoprotein, TG triglycerides, NGT normal glucose tolerance, history of
CVD history of cardiovascular diseaseStatistical analyses
The descriptive analyses are given in percentages (for
categorical variables) and means with standard devia-
tions (for continuous variables). The normality of distri-
bution was assessed by skewness and kurtosis analysis.
Differences between groups were assessed using chi-
square and t-test for dependent groups (respectively for
the type of data). For comparison of the 3 measurements
the repeated measures ANOVA and main effect compar-
isons (pairwise t-tests) with Bonferroni correction was
performed. All analyses were competed with SPSS v.20.
P-value of < 0.05 was considered as the level of statistical
significance.Results
105 middle aged participants (age 56.6 (SD = 10.7)),
slightly obese (BMI 31.11 (SD = 4.9)), with high risk of
developing diabetes (FRS 18.57 (SD = 3.09) completed
all 3 examinations.
Baseline characteristics of completers vs non-completers
Baseline characteristics of completers (n = 105) vs non-
completers (n = 79) is given in Table 1. At baseline, non-
completers in comparison with completers were heavier
(89.7 vs 82.85 kg), had higher BMI (32.66 vs 31.11 kg/m2)
and waist circumference 101.23 vs 96.67 cm) (p for
all <0.05). Additionally non-completers had higher
systolic and diastolic blood pressure (134.8 vs 130.7
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well as higher fasting and OGTT glucose level (5.55 vs
5.22 (p = 0.01) and 7.1 vs 5.77 mmol/l (p < 0.001), respect-
ively. Completers had normal glucose tolerance (NGT)
more often than non-completers (76% vs 63% (p = 0.04)).
13% of the completers and 31.9% of the non-completers
were men (p = 0.004). No other biochemical, anthropo-
metric and sociodemographic differences between com-
pleters and non-completers were found.
Clinical outcomes for completers
Clinical and metabolic characteristics of completers from
baseline to year 1 and 3 is given in Table 2. Using repeated
measures statistical analysis, we found significant changes
in the following parameters: weight (p = 0.048), BMI
(p = 0.001), glucose level (p = 0.037), total cholesterol
(p=0.013), TG (p= 0.061) and FINDRISC (p = 0.001)
Mean weight decreased by 2.27 kg (SD = 5.24) after one
year (p = 0.001). After 3 years a weight gain of 1.13 kg
(SD = 4.6) (p = 0.0405) was noted. Nonetheless, the mean
weight was still lower compared to baseline by 1.14 kg
(SD = 5.8) (ns).
The same trend of changes after 1 and 3 years was ob-
served for BMI (p < 0.001 for both time points). Total
cholesterol level diminished after one year by 0.26 mmol/l
(SD = 1.16) (p = 0.065) and by 0.29 mmol/l (SD = 1.03)
after 3 years (p= 0.016). TG decreased after one year by
0.14 mmol/l (SD = 1.33) (ns) and by 0.23 (SD = 1.22) (ns)
after 3 years. FINDRISC went down after one year by 2.8
(SD = 3.6) (p = 0.001) and by 2.26 (SD = 4.27) after 3 years
(p = 0.001). We also observed an increase of fasting glucoseTable 2 Repeated measures analysis of clinical and metabolic chara
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No. Mean SD Mean SD Mean
Weight (kg) 105 82,85 15,20 −2,27 5,25 −1,14
BMI (kg/m2) 105 31,10 4,93 −0,84 1,91 −0,35
WC (cm) 105 96,67 11,41 −3,95 5,71 −0,62
SBP (mmHg) 105 130,72 14,09 −1,97 15,58 0,11
DBP (mmHg) 105 80,80 8,97 −1,36 9,10 −0,56
Fasting glucose
(mmol/l)
105 5,22 0,72 0,17 0,67 0,13
2-h OGTT glucose
(mmol/l)
105 5,78 1,75 0,29 2,12 0,21
TCH ( mmol/l) 105 5,55 0,94 −0,26 1,16 −0,29
HDL ( mmol/l) 105 1,39 0,35 −0,05 0,28 −0,05
TG ( mmol/l) 105 1,77 1,38 −0,14 1,33 −0,23
FINDRISK 105 18,57 3,09 −2,81 3,64 −2,27
Key: BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure
lipoprotein, TG triglyceridesafter one year by 0.17 mmol/l (SD = 0.67) (p = 0.066) and
by 1.12 mmol/l (SD = 0.68) (p = 0.067) after 3 years.
At baseline 76% of participants had NGT, 10% IFG
and 14% IGT. After 1 year of the study 73% of patients
had NGT, 2% DM, 5% IFG and 20% IGT. After 3 years
74% of participants had NGT, 7% DM, 9% IFG and
11% IGT.
After 1 year 15% of baseline NGT patients converted
to IFG or IGT and 1% to DM. After 3 years 19% of base-
line NGT patients converted to IFG or IGT and 1% to
DM. 10% and 20% of baseline IFG patients converted to
DM after 1 and 3 years, respectively. Among baseline
IGT participants none developed DM after 1 year but
27% converted to DM after 3 years of the study. 2 people
with DM diagnosed after 1 year participated in the 3
year examination ( treated with diet only). They were
categorized as DM again. After one year 27% partici-
pants lost weight by > 5%, 43% by < 5% and 31% did not
change or increase body mass. After 3 years 19% partici-
pants maintained lower weight decreased by > 5%, 37%
decreased by < 5%, and 44% did not change weight or
increased body mass.
Discussion
The results of this study show that type 2 diabetes pre-
vention through lifestyle intervention in a primary health
care setting is feasible and effective, and the results can
be maintained during long-time observation. The evi-
dence from RCTs confirmed that through lifestyle inter-
vention including dietary modification, weight loss and
physical activity, the reduction in type 2 diabetescteristic from baseline to year 1 and 3 in the Diabetes in Europe
ion (DE-PLAN) project (n = 105)









5,83 0,000 0,143 0,041 0,048
2,18 0,000 0,000 0,018 0,000
7,40 0,000 1,000 0,000 0,100
16,50 0,593 1,000 0,472 0,313
10,25 0,385 1,000 0,955 0,579
0,68 0,066 0,067 1,000 0,037
2,45 0,485 1,000 1,000 0,373
1,03 0,065 0,016 1,000 0,013
0,54 0,027 0,053 1,000 0,352
1,23 0,130 0,120 0,560 0,061
4,28 0,000 0,000 0,503 0,000
, OGTT oral glucose tolerance test, TCH total cholesterol, HDL high density
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tion. [5–8]. While there is evidence from RCTs, there
are only a few long-time observations of implementation
studies [21, 24]. In our real life implementation study
conducted by trained nurses we demonstrated a modest
weight reduction, by 2.27 kg, after 1 year of intervention.
The change was subtle, however, it was accompanied by
a reduction of total blood cholesterol, triglycerides as
well as a lowered diabetes risk. Results achieved at one
year were further maintained at 3 year follow-up.
Similar results were achieved in The Good Ageing in
Lahti Region (GOAL) Lifestyle Implementation trial. This
study was also designed for primary health care setting with
lifestyle and risk reduction objectives based on the DPS.
Similarly, the intervention was conducted by study nurses
and consisted of 6 group counselling sessions [14, 21]. Pa-
tients were examined in year 1 of the intervention and
after 3 years of the follow-up. The results after one year
were also modest with the mean body mass reduction of
0.8 (SD = 4.5 kg) followed by modest but significant re-
duction in waist circumference, fasting glucose and total
cholesterol. The 3 year follow-up body weight reduction
was 1.0 (SD = 5.6 kg) which is comparable to our results.
Furthermore, total cholesterol decrease and triglycerides
reduction were also maintained after 3 years.
In our study the conversion rate to diabetes in all par-
ticipants (baseline IGT, IFG and NGT) reached 2% after
1 year and 7% after 3 years. Data concerning the conver-
sion rate are not easy to compare between different
studies as various design, time of observation and risk of
intervened people were applied. In the GOAL study, for
example, the conversion rate from IGT to type 2 dia-
betes was 12% at 3 year follow-up while in the DPS
study, where all participants had baseline IGT, the con-
version rate was 9% in the intervention and 20% in the
control group [4, 21]. The lower conversion rate in our
study might be explained by lower risk level at baseline.
In the DPS all participants had IGT at baseline, while in
our study only 10% exhibited IFG and 14% IGT. How-
ever, the very low conversion rate to diabetes in our
study should be regarded as an evidence of successful
short and long term intervention.
In a review focusing on translational lifestyle interven-
tions, Johnson et al. concluded that effectiveness could
not be easily demonstrated with clinical parameters,
such as blood glucose or T2DM risk [19].
Given the relatively short follow-up time and small
sample size, real life prevention studies may have suffi-
cient statistical power to measure change in weight ra-
ther than T2DM incidence [19]. Therefore, weight loss
in these studies can be regarded as a marker for poten-
tial prevention in the long-term [19, 20].
Additionally, the reduction in FINDRISC score in our
study, which changed from 18.57 at baseline to 15.76 atyear 1 and 16.30 at year 3 can be used as a surrogate
marker for diabetes risk reduction.
In the DPP study, weight loss was reported to be the
dominant factor in T2DM prevention, with a loss of 5
kg explaining the 55% reduction incidence of T2DM
over 3 years follow-up [24]. In the RCTs weight loss was
correlated with the intensity of the delivered program. It
is important to remember that intervention given in
RTCs is typically incomparable to translational studies,
which typically provide a less intensive, low budget inter-
vention adapted to local and cultural possibilities. Con-
sequently, as seen also in our study, the achieved weight
reduction is usually modest compared with RCTs. Also,
the percentage of people who lost > 5% of initial weight
was substantially lower in our study than in the DPS or
DPP studies (27% after one year and 19% after 3 years of
the follow-up). However, modest weight reduction in
our study should be regarded as a measure of success. In
general population there is a weight increase by 0.5 kg
per year, thus even small weight reduction or weight
maintenance should be considered important achieve-
ments in diabetes prevention [25].
Although in our study there was a weight regain of
1.13 kg after 3 years, the weight decrease by 1.14 kg was
still maintained even though the metabolic changes ob-
served after intervention were still present at 3 year
follow-up. According to the DPS, body weight during
follow-up increased gradually in both groups but a sta-
tistically significant difference between the study groups
prevailed [6]. Moreover, both metabolic improvements
and lifestyle changes continued over time in those who
were intervened [6].
In the meta-analysis of 22 real life implementation
studies conducted by Dunkley et al. the mean proportion
of weight lost (%) at 12 months follow-up was 2.6%. It
was concluded that despite the drop-off in intervention
effectiveness in translational studies, the modest level of
weight loss found in the analysis is still likely to have a
clinically meaningful effect on diabetes incidence. The
rate of progression to diabetes was calculated 34 per
1000 person-years which suggests that the real world
lifestyle intervention studies achieved lower diabetes
progression rates in comparison to natural progression
rates in high risk individuals [20].
Some limitations of our study need to be discussed. The
participants in our study were volunteers, and similarly to
many other studies, our study predominantly attracted
women, who accounted for 87% of participating in both
examinations. Thus, our results might not be generalized
in reference to both sexes. In addition, rather modest re-
sults obtained in our study might be influenced by female
sex domination, whose success in previous diabetes pre-
vention studies was meager when compared to men [26].
It also implies the need for further studies on sex specific
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also confirmed that people who participate in epidemio-
logical studies have a healthier profile, are less obese and
have better blood pressure and biochemical profiles than
non-attenders, therefore the results of the intervention
might be less obvious in those baseline healthier people
[27]. In our study there were no particular socioeconomic
differences between completers and non-completers.
However low socioeconomic status could be related to
less frequent use of healthcare services despite poorer
health status [28]. These observations highlight the need
to develop lifestyle interventions further in order to in-
crease participation of males and particularly those who
are at high risk [18, 20].
A modified program based on the DE-PLAN spon-
sored by the local self-government is being continued in
Krakow. Methodology, results and experience from the
DE-PLAN project were used in the preparation of the
European guidelines for the prevention of type 2 dia-
betes and the toolkit for diabetes prevention in Europe
[29, 30]. There are also some other European initiatives
on diabetes type 2 prevention and early prevention of
diabetes complications following the DE-PLAN project:
the IMAGE (Development and Implementation of a
European Guideline and Training Standards for Diabetes
Prevention), the MANAGE CARE (Active Ageing with
Type 2 Diabetes as Model for the Development and
Implementation of Innovative Chronic Care Management
in Europe) and the ePREDICE (Early Prevention of
Diabetes Complications in People with Hyperglycaemia in
Europe) projects (www.idf.org).Conclusions
Type 2 diabetes prevention in primary health care setting
through lifestyle intervention delivered by trained nurses
leads to modest weight reduction, which is accompanied
by favorable cardiovascular risk factors changes and
diabetes risk reduction. These beneficial outcomes can be
maintained at a 3-year follow-up.Key messages
Type 2 diabetes prevention in high risk individuals sub-
ject to lifestyle intervention may provide long-term ben-
efits in biological parameters such as body weight and
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